World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

Login Register
World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

SJIF Impact Factor: 6.842

Abstract

THE STUDY OF MITOMYCIN AND BCG COMPARISON IN URINARY BLADDER TUMOR TREATMENT IN A TERTIARY CARE HOSPITAL

*Yasir Mehmood, Malik Muhammad Shahzad Awan and Hassan Tariq

ABSTRACT

Objective: The primary aim of this research was to Compare mitomycin C and BCG in urinary bladder treatment to determine better agents with lower complications and good results. Materials and Methods: The study was conducted between May 2019 and January 2020 at Nishtar Hospital in Multan, Pakistan. There were 60 patients with a urinary bladder tumor. Results: Complications such as fever, hematuria, and dysuria were more linked to BCG, though the recurrence rate compared to MMC was lower. Conclusion: BCG is more suitable than MMC for the treatment of urinary bladder cancer.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR